Krawitz HE - Search Results

1

The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: a prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05).

Ball DL, Fisher RJ, Burmeister BH, Poulsen MG, Graham PH, Penniment MG, Vinod SK, Krawitz HE, Joseph DJ, Wheeler GC, McClure BE. Ball DL, et al. Among authors: krawitz he. Radiother Oncol. 2013 Mar;106(3):305-11. doi: 10.1016/j.radonc.2012.12.003. Epub 2013 Jan 16. Radiother Oncol. 2013. PMID: 23333017

2

Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 database.

Ball DL, Fisher R, Burmeister B, Graham P, Joseph D, Penniment M, Krawitz H, Wheeler G, Poulsen M, Vinod S, McClure B. Ball DL, et al. J Thorac Oncol. 2006 Sep;1(7):667-72. J Thorac Oncol. 2006. PMID: 17409934 Free article.

3

The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck.

Daly T, Poulsen MG, Denham JW, Peters LJ, Lamb DS, Krawitz H, Hamilton C, Keller J, Tripcony L, Walker Q. Daly T, et al. Radiother Oncol. 2003 Aug;68(2):113-22. doi: 10.1016/s0167-8140(03)00198-1. Radiother Oncol. 2003. PMID: 12972305 Clinical Trial.

4

A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06.

Burmeister BH, Mark Smithers B, Burmeister E, Baumann K, Davis S, Krawitz H, Johnson C, Spry N; Trans Tasman Radiation Oncology Group. Burmeister BH, et al. Radiother Oncol. 2006 Nov;81(2):136-42. doi: 10.1016/j.radonc.2006.10.001. Epub 2006 Oct 24. Radiother Oncol. 2006. PMID: 17064803 Clinical Trial.

5

Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study.

Macann A, Fua T, Milross CG, Porceddu SV, Penniment M, Wratten C, Krawitz H, Poulsen M, Tang CI, Morton RP, Hay KD, Thomson V, Bell ML, King MT, Fraser-Browne CL, Hockey HU. Macann A, et al. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):572-9. doi: 10.1016/j.ijrobp.2013.11.226. Int J Radiat Oncol Biol Phys. 2014. PMID: 24521675 Clinical Trial.

6

Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?

Denham JW, Peters LJ, Johansen J, Poulsen M, Lamb DS, Hindley A, O'Brien PC, Spry NA, Penniment M, Krawitz H, Williamson S, Bear J, Tripcony L. Denham JW, et al. Radiother Oncol. 1999 Aug;52(2):157-64. doi: 10.1016/s0167-8140(99)00107-3. Radiother Oncol. 1999. PMID: 10577701 Clinical Trial.

7

A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.

Poulsen MG, Denham JW, Peters LJ, Lamb DS, Spry NA, Hindley A, Krawitz H, Hamilton C, Keller J, Tripcony L, Walker Q. Poulsen MG, et al. Radiother Oncol. 2001 Aug;60(2):113-22. doi: 10.1016/s0167-8140(01)00347-4. Radiother Oncol. 2001. PMID: 11439206 Clinical Trial.

8

Acute toxicity and cost analysis of a phase III randomized trial of accelerated and conventional radiotherapy for squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group study.

Poulsen M, Denham J, Spry N, Lamb D, Peters L, Krawitz H, Penniment M, Williamson S, Tripcony L. Poulsen M, et al. Australas Radiol. 1999 Nov;43(4):487-94. doi: 10.1046/j.1440-1673.1999.00718.x. Australas Radiol. 1999. PMID: 10901965 Clinical Trial.

9

A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases.

Bydder S, Spry NA, Christie DR, Roos D, Burmeister BH, Krawitz H, Davis S, Joseph DJ, Poulsen M, Berry M. Bydder S, et al. Australas Radiol. 2003 Sep;47(3):284-8. doi: 10.1046/j.1440-1673.2003.01177.x. Australas Radiol. 2003. PMID: 12890250 Clinical Trial.

10

Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01). Trans-Tasman Radiation Oncology Group.

Hamilton C, Poulsen M, Walker Q, Krawitz H, Hindley A, Spry N, Peters L, Lamb D, Denham J, Steigler A. Hamilton C, et al. Australas Radiol. 1999 May;43(2):227-32. doi: 10.1046/j.1440-1673.1999.00639.x. Australas Radiol. 1999. PMID: 10901907 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page